Table 1.
Association between clinicopathological features and miR-125a-5p expression. *p < 0.05 indicates a significant association among the variables.
miR-125a-5p expression in tumour |
||||
---|---|---|---|---|
n | high (n = 292, %) | low (n = 92, %) | p-value | |
age, years | 0.393 | |||
<65 | 170 | 34.0 | 45.0 | |
≥65 | 214 | 66.0 | 55.0 | |
gender | 0.521 | |||
male | 180 | 48.4 | 39.1 | |
female | 204 | 51.6 | 60.9 | |
T stage | 0.008* | |||
T1 | 6 | 3.2 | 3.0 | |
T2 | 21 | 16.1 | 5.7 | |
T3 | 172 | 46.9 | 29.1 | |
T4 | 185 | 33.8 | 62.2 | |
N stage | 0.005* | |||
N0 | 94 | 67.7 | 40.7 | |
N1 | 158 | 25.7 | 34.7 | |
N2 | 132 | 6.6 | 24.6 | |
M stage | 0.001* | |||
M0 | 268 | 96.8 | 81.3 | |
M1 | 116 | 3.2 | 18.7 | |
AJCC stage | 0.008* | |||
I | 72 | 17.7 | 7.2 | |
II | 119 | 46.8 | 31.9 | |
III | 125 | 32.2 | 42.0 | |
IV | 68 | 3.3 | 18.9 | |
differentiation | 0.002* | |||
high | 88 | 66.0 | 32.0 | |
moderate | 168 | 27.4 | 41.0 | |
low | 128 | 6.6 | 27.0 | |
vascular invasion | 0.002* | |||
yes | 273 | 96.8 | 91.4 | |
no | 111 | 3.2 | 8.6 |